date:Jun 16, 2012
s in 2004 that is infuriating the lutein sector, none more than the biggest players, DSM and Kemin.
level of unclarity that's unprecedented
The companies sent us a statement expressing their frustration at the NDAs trajectory on the matter, while remaining upbeat a claim could be won.
The opinion of EFSA presents us with a level of unclarity that's unprecedented,said DSM VP of nutrition and health, Bas van Buijtenen.
EFSA has apparently come to the conclusion that the evidence on lutein and